{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T10:34:12Z","timestamp":1791455652804,"version":"4.3.4"},"reference-count":20,"publisher":"JMIR Publications Inc.","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JMIRx Med"],"abstract":"Abstract<\/jats:title>\n \n Background<\/jats:title>\n \n Long-term oxygen therapy (LTOT) improves outcomes in selected patients with severe chronic hypoxemia, but conventional LTOT uses fixed oxygen flow prescriptions that may not reflect changing needs during activity, sleep, or exacerbations. AI and automated oxygen systems may support continuous peripheral capillary oxygen saturation (SpO\n 2<\/jats:sub>\n ) monitoring, signal-quality assessment, and adaptive oxygen titration. Evidence comparing AI-driven and non-AI automated approaches across performance, clinical readiness, LTOT applicability, and equity remains limited.\n <\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n \n This systematic review synthesized peer-reviewed evidence on AI-driven and automated systems for continuous SpO\n 2<\/jats:sub>\n monitoring or oxygen titration relevant to adult LTOT, focusing on accuracy, motion robustness, clinical performance, demographic equity, and readiness for home or ambulatory deployment.\n <\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n \n This review followed PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) 2020 and PRISMA-S (Preferred Reporting Items for Systematic Reviews and Meta-Analyses\u2013Search). PubMed, IEEE Xplore, Springer Link, ACM Digital Library, and supplementary MDPI publisher-level searches were searched for English-language peer-reviewed studies published during 2000 to January 2025. Eligible studies evaluated AI-driven or automated systems for continuous SpO\n 2<\/jats:sub>\n monitoring or oxygen titration in adult LTOT-relevant populations and addressed motion artifact, low-perfusion signal management, skin tone bias, or prolonged signal stability. Two reviewers independently screened and extracted data; disagreements were resolved with a third reviewer. Risk of bias was assessed using an adapted Risk of Bias in Non-randomized Studies of Interventions (ROBINS-I) framework. Heterogeneous designs and outcomes precluded meta-analysis, so findings were synthesized narratively following Popay et al.\n <\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n Of 928 records (926 from databases or platforms and 2 from manual reference screening), 912 remained after deduplication, 61 full texts were assessed, and 8 studies were included. Five studies evaluated AI-based systems and 3 evaluated automated non-AI oxygen delivery. AI models reported SpO\n 2<\/jats:sub>\n estimation mean absolute error as low as 0.57% and root mean square error as low as 0.69%, but most were simulated, retrospective, or non\u2013chronic obstructive pulmonary disease (COPD) specific. Only Cabanas et al reported skin tone\u2013stratified bias analysis. Automated systems showed stronger clinical deployment evidence: O\n 2<\/jats:sub>\n matic maintained the target SpO\n 2<\/jats:sub>\n 85.1% of the time versus 46.6% with manual titration, while Cirio and Nava reported mean SpO\n 2<\/jats:sub>\n of 95% versus 93% manually. Risk of bias was moderate to serious, mainly due to participant selection, limited demographic reporting, and algorithmic transparency.\n <\/jats:p>\n <\/jats:sec>\n \n Conclusions<\/jats:title>\n AI-driven and automated LTOT-relevant systems address complementary gaps. AI approaches show promise for signal interpretation and personalized prediction, whereas rule-based automated systems have stronger near-term clinical evidence for oxygen titration. Evidence is limited by small study numbers, heterogeneous outcomes, limited COPD or home LTOT validation, and sparse equity reporting. Future work should prioritize longitudinal validation in diverse LTOT populations, prespecified equity outcomes, failure-mode reporting, and hybrid architectures combining AI signal intelligence with safety-critical automated control.<\/jats:p>\n <\/jats:sec>","DOI":"10.2196\/76506","type":"journal-article","created":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T17:15:06Z","timestamp":1788542106000},"page":"e76506-e76506","source":"Crossref","is-referenced-by-count":3,"title":["AI-Driven and Automated Systems for Continuous Oxygen Saturation Monitoring in Long-Term Oxygen Therapy: Systematic Review"],"prefix":"10.2196","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-4834-5698","authenticated-orcid":false,"given":"Suman","family":"Kadariya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-4329-7141","authenticated-orcid":false,"given":"Prajita","family":"Niraula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-8244-2453","authenticated-orcid":false,"given":"Bishal","family":"Poudel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-6094-5831","authenticated-orcid":false,"given":"Sujan","family":"Kadariya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1010","published-online":{"date-parts":[[2026,10,7]]},"reference":[{"key":"R1","unstructured":"Global health estimates: life expectancy and leading causes of death and disability. World Health Organization. 2020. URL: https:\/\/www.who.int\/data\/gho\/data\/themes\/mortality-and-global-health-estimates [Accessed 15-09-2026]"},{"issue":"3","key":"R2","doi-asserted-by":"publisher","first-page":"391","DOI":"10.7326\/0003-4819-93-3-391","article-title":"Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial","volume":"93","author":"Nocturnal Oxygen Therapy Trial Group","journal-title":"Ann Intern Med"},{"issue":"8222","key":"R3","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/S0140-6736(81)91970-X","article-title":"Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema","volume":"1","journal-title":"Lancet"},{"key":"R4","unstructured":"Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Global Initiative for Chronic Obstructive Lung Disease (GOLD); 2024. URL: https:\/\/goldcopd.org\/wp-content\/uploads\/2024\/02\/GOLD-2024_v1.2-11Jan24_WMV.pdf [Accessed 15-09-2026]"},{"issue":"25","key":"R5","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1056\/NEJMc2029240","article-title":"Racial bias in pulse oximetry measurement","volume":"383","author":"Sjoding","journal-title":"N Engl J Med"},{"issue":"7","key":"R6","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1001\/jamainternmed.2022.1906","article-title":"Racial and ethnic discrepancy in pulse oximetry and delayed identification of treatment eligibility among patients with COVID-19","volume":"182","author":"Fawzy","journal-title":"JAMA Intern Med"},{"issue":"2","key":"R7","doi-asserted-by":"publisher","DOI":"10.3390\/bioengineering10020167","article-title":"Machine learning-based respiration rate and blood oxygen saturation estimation using photoplethysmogram signals","volume":"10","author":"Shuzan","journal-title":"Bioengineering (Basel)"},{"issue":"11","key":"R8","doi-asserted-by":"publisher","DOI":"10.3390\/bioengineering11111061","article-title":"Evaluating AI methods for pulse oximetry: performance, clinical accuracy, and comprehensive bias analysis","volume":"11","author":"Cabanas","journal-title":"Bioengineering (Basel)"},{"key":"R9","doi-asserted-by":"publisher","DOI":"10.1109\/e-Science58273.2023.10254844","article-title":"Analyzing distinct neural network models for oxygen saturation prediction towards a personalized COPD management","author":"Pascual","journal-title":"IEEE Int Conf e-Sci"},{"issue":"3","key":"R10","doi-asserted-by":"publisher","DOI":"10.3390\/s24030764","article-title":"Innovative predictive approach towards a personalized oxygen dosing system","volume":"24","author":"Pascual-Salda\u00f1a","journal-title":"Sensors (Basel)"},{"issue":"22","key":"R11","doi-asserted-by":"publisher","DOI":"10.3390\/s24227193","article-title":"Machine learning applied to reference signal-less detection of motion artifacts in photoplethysmographic signals: a review","volume":"24","author":"Arg\u00fcello-Prada","journal-title":"Sensors (Basel)"},{"key":"R12","doi-asserted-by":"publisher","DOI":"10.2147\/COPD.S183762","article-title":"Automated oxygen control with O2matic during admission with exacerbation of COPD","volume":"13","author":"Hansen","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"4","key":"R13","doi-asserted-by":"publisher","DOI":"10.3390\/s20041178","article-title":"Automated home oxygen delivery for patients with COPD and respiratory failure: a new approach","volume":"20","author":"Sanchez-Morillo","journal-title":"Sensors (Basel)"},{"issue":"4","key":"R14","doi-asserted-by":"publisher","first-page":"429","DOI":"10.4187\/respcare.00983","article-title":"Pilot study of a new device to titrate oxygen flow in hypoxic patients on long-term oxygen therapy","volume":"56","author":"Cirio","journal-title":"Respir Care"},{"key":"R15","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","journal-title":"BMJ"},{"issue":"1","key":"R16","doi-asserted-by":"publisher","DOI":"10.1186\/s13643-020-01542-z","article-title":"PRISMA-S: an extension to the PRISMA Statement for reporting literature searches in systematic reviews","volume":"10","author":"Rethlefsen","journal-title":"Syst Rev"},{"key":"R17","unstructured":"Popay J Roberts H Sowden A et al. Guidance on the conduct of narrative synthesis in systematic reviews: a product from the ESRC methods programme. Lancaster University; 2006. URL: https:\/\/database.inahta.org\/article\/2684? [Accessed 15-09-2026]"},{"issue":"9","key":"R18","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1038\/s41591-020-1034-x","article-title":"Reporting guidelines for clinical trial reports for interventions involving artificial intelligence: the CONSORT-AI extension","volume":"26","author":"Liu","journal-title":"Nat Med"},{"key":"R19","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2022-070904","article-title":"Reporting guideline for the early stage clinical evaluation of decision support systems driven by artificial intelligence: DECIDE-AI","volume":"377","author":"Vasey","journal-title":"BMJ"},{"key":"R20","unstructured":"Artificial intelligence\/machine learning (AI\/ML)-based software as a medical device (SaMD) action plan. U.S. Food and Drug Administration (FDA); Jan 2021. URL: https:\/\/www.fda.gov\/media\/145022\/download [Accessed 15-09-2026]"}],"container-title":["JMIRx Med"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T21:15:12Z","timestamp":1791407712000},"score":1,"resource":{"primary":{"URL":"https:\/\/xmed.jmir.org\/2026\/1\/e76506"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,7]]},"references-count":20,"URL":"https:\/\/doi.org\/10.2196\/76506","relation":{},"ISSN":["2563-6316"],"issn-type":[{"value":"2563-6316","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,7]]},"article-number":"v7i3e76506"}}